Furosemide (Page 4 of 4)

Geriatric Patients

In general, dose selection and dose adjustment for the elderly patient should be cautious, usually starting at the low end of the dosing range (see PRECAUTIONS: Geriatric Use).

HOW SUPPLIED

Furosemide Tablets, USP are available as tablets for oral administration. Each tablet for oral administration contains 40 mg of furosemide, USP.

The 40 mg tablets are white, round, scored tablets debossed with MYLAN over 216 on one side and the tablet and 40 on the other side. They are available as follows:

NDC 67046-219-07 blisterpacks of 7

NDC 67046-219-14 blisterpacks of 14

NDC 67046-219-15 blisterpacks of 15

NDC 67046-219-20 blisterpacks of 20

NDC 67046-219-21 blisterpacks of 21

NDC 67046-219-28 blisterpacks of 28

NDC 67046-219-30 blisterpacks of 30

NDC 67046-219-60 blisterpacks of 60

Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]

Protect from light.

Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure. Exposure to light may cause a slight discoloration. Discolored tablets should not be dispensed.


Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.

REVISED APRIL 2016
FUR:R28

Repackaged by:
Contract Pharmacy Services-PA
125 Titus Ave Suite 200
Warrington, PA 18976 USA

Rev: Original—2017.10.02—NJW

PRINCIPAL DISPLAY PANEL — 40 mg

NDC 67046-219-30

Furosemide
Tablets, USP
40 mg

Rx only 30 Tablets

Each tablet contains 40 mg of
furosemide, USP.

Dispense in a tight, light-resistant
container as defined in the USP
using a child-resistant closure.

Keep container tightly closed.

Keep this and all medication
out of the reach of children.

Store at 20° to 25°C (68° to 77°F).
[See USP Controlled Room
Temperature.]

Protect from light.

Usual Dosage: See accompanying
prescribing information.

Mylan Pharmaceuticals Inc.
Morgantown, WV 26505 U.S.A.

Mylan.com

RM0216A10

Furosemide Tablets, USP 40 mg Bottle Label
(click image for full-size original)
FUROSEMIDE
furosemide tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:67046-219(NDC:0378-0216)
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
FUROSEMIDE (FUROSEMIDE) FUROSEMIDE 40 mg
Inactive Ingredients
Ingredient Name Strength
SILICON DIOXIDE
LACTOSE MONOHYDRATE
CELLULOSE, MICROCRYSTALLINE
STARCH, CORN
STEARIC ACID
Product Characteristics
Color white Score 2 pieces
Shape ROUND Size 8mm
Flavor Imprint Code MYLAN;216;40
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:67046-219-07 7 TABLET in 1 BLISTER PACK None
2 NDC:67046-219-14 14 TABLET in 1 BLISTER PACK None
3 NDC:67046-219-15 15 TABLET in 1 BLISTER PACK None
4 NDC:67046-219-20 20 TABLET in 1 BLISTER PACK None
5 NDC:67046-219-21 21 TABLET in 1 BLISTER PACK None
6 NDC:67046-219-28 28 TABLET in 1 BLISTER PACK None
7 NDC:67046-219-30 30 TABLET in 1 BLISTER PACK None
8 NDC:67046-219-60 60 TABLET in 1 BLISTER PACK None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA018487 10/02/2017
Labeler — Contract Pharmacy Services-PA (945429777)
Establishment
Name Address ID/FEI Operations
Coupler Enterprises Inc. 945429777 repack (67046-219)

Revised: 10/2017 Contract Pharmacy Services-PA

Page 4 of 4 1 2 3 4

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2024. All Rights Reserved.